,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-08-31 08:09:00,Shareholders of Veeva Systems (NYSE: VEEV) have had a lot to cheer about recently.,0.5741779208183289,0.012369189411401749,0.4134528934955597,positive,0.561808705329895
1,2018-08-31 08:09:00,The company -- which aims to provide a one-stop cloud solution for all the needs of pharmaceutical companies -- has seen its stock almost quintuple since February 2016 on the back of consistently strong earnings reports .,0.9474753141403198,0.0288825873285532,0.02364211156964302,positive,0.9185927510261536
2,2018-08-31 08:09:00,"During that run, Veeva Vault -- a repository for the data needed to bring a compound from idea to clinical trials to market -- has been the star of the show .",0.2928159534931183,0.016299786046147346,0.6908842921257019,neutral,0.2765161693096161
3,2018-08-31 08:09:00,"But in the most recent earnings call , management highlighted three more specific areas that in-the-know investors should keep an eye on.",0.046287886798381805,0.014356812462210655,0.9393552541732788,neutral,0.031931072473526
4,2018-08-31 08:09:00,"Growth could be coming back to the commercial cloud

For the first half-dozen years as a company, Veeva focused on a suite of customer relationship management (CRM) tools.",0.18382765352725983,0.006104544270783663,0.8100677728652954,neutral,0.17772310972213745
5,2018-08-31 08:09:00,These tools helped a drug company's sales force monitor and track key drug sales data.,0.1505965143442154,0.008155105635523796,0.8412484526634216,neutral,0.14244140684604645
6,2018-08-31 08:09:00,"They are now considered part of Veeva's ""commercial cloud"" division.",0.012750953435897827,0.007238281425088644,0.9800107479095459,neutral,0.005512672010809183
7,2018-08-31 08:09:00,"While this is still an important part of the business -- providing stable, high-margin, subscription revenue -- growth has slowed and taken a back seat to the aforementioned Veeva Vault.",0.02438391000032425,0.9321807622909546,0.04343528673052788,negative,-0.9077968597412109
8,2018-08-31 08:09:00,"But CEO and founder Peter Gassner said there could be a new growth initiative on the horizon:

Veeva has already disrupted several custom systems at Big Pharma companies, and Nitro would be another tool.",0.7564715147018433,0.02896750159561634,0.21456104516983032,positive,0.7275040149688721
9,2018-08-31 08:09:00,Nitro would widen Veeva's moat via high switching costs -- no one would want to migrate all of that data unless absolutely necessary.,0.2004244476556778,0.019112316891551018,0.7804632782936096,neutral,0.18131212890148163
10,2018-08-31 08:09:00,"But because of the AI component, it would also add a sneaky network effect: The more customers that use Nitro, the more precise the company's algorithms become, which entices further customers, making the algorithms even better.",0.5590376853942871,0.027455147355794907,0.4135070741176605,positive,0.5315825343132019
11,2018-08-31 08:09:00,"Progress continues to be made outside of life sciences

When the idea of Veeva was born, the intent was to focus solely on life sciences companies.",0.08285271376371384,0.0042363787069916725,0.9129109382629395,neutral,0.07861633598804474
12,2018-08-31 08:09:00,"But because of the success of Veeva Vault, the company started hearing from more and more potential customers in other industries that wanted access to the software.",0.762135922908783,0.014948074705898762,0.22291606664657593,positive,0.7471878528594971
13,2018-08-31 08:09:00,This was especially true of companies in highly regulated fields like chemicals and consumer packaged goods.,0.035431209951639175,0.007957488298416138,0.9566113352775574,neutral,0.027473721653223038
14,2018-08-31 08:09:00,Thus was born Vault QualityOne -- a hybrid of offerings for non-pharmaceutical companies.,0.15617725253105164,0.005739492829889059,0.8380832076072693,neutral,0.15043775737285614
15,2018-08-31 08:09:00,"It was rolled out on a limited basis last year, and continues to progress, according to Gassner:

The initiative is nowhere near big enough to warrant being broken out in SEC filings, but long-term investors should continue to listen in to conference calls to see if this offering ever reaches a tipping point that could meaningfully add to the company's bottom line.",0.8545267581939697,0.01913474127650261,0.12633852660655975,positive,0.8353919982910156
16,2018-08-31 08:09:00,"Vault EDC is making strides toward an enormous goal

Finally, I want to highlight Veeva's efforts in electronic data capture (EDC).",0.7206970453262329,0.011583687737584114,0.2677193284034729,positive,0.709113359451294
17,2018-08-31 08:09:00,"In the most basic sense, this is the practice of inputting data from clinical trials via electronic input instead of paper form.",0.02768518775701523,0.00687493197619915,0.9654399156570435,neutral,0.020810255780816078
18,2018-08-31 08:09:00,"As you might expect, this is massively important for drug companies.",0.19134806096553802,0.005963935516774654,0.8026880025863647,neutral,0.1853841245174408
19,2018-08-31 08:09:00,"Currently, Oracle and Medidata Solutions own most of the market share.",0.015248109586536884,0.0060848090797662735,0.978667140007019,neutral,0.00916330050677061
20,2018-08-31 08:09:00,But the trends are looking rosier every quarter for Veeva.,0.5095328688621521,0.05610423535108566,0.43436285853385925,positive,0.45342862606048584
21,2018-08-31 08:09:00,"Per Gassner:

Gassner is making no secret that winning over customers will be tougher here, as there are already established cloud players.",0.10267218202352524,0.5815550684928894,0.31577274203300476,negative,-0.47888287901878357
22,2018-08-31 08:09:00,"However, if a drug company had the option to transition to Veeva EDC -- given that it was already using the company for its CRM and other trial-related Vault needs -- it's not out of the question that Veeva could have a real coup on its hands.",0.2563124895095825,0.009961340576410294,0.7337261438369751,neutral,0.24635115265846252
23,2018-08-31 08:09:00,"Simplifying everything for drug companies under one umbrella is enticing, and Veeva might have the momentum to see it through.",0.7270650863647461,0.011391246691346169,0.2615436315536499,positive,0.7156738638877869
24,2018-08-31 08:09:00,"Over the short term, none of these three will be major drivers for stock-price movement.",0.020508211106061935,0.013505763374269009,0.9659860134124756,neutral,0.007002447731792927
25,2018-08-31 08:09:00,Sales and profitability figures will drive that narrative.,0.42097991704940796,0.016521897166967392,0.5624982118606567,neutral,0.40445801615715027
26,2018-08-31 08:09:00,"However, for long-term investors who plan on holding for five or more years, these three businesses -- Nitro, QualityOne, and EDC -- represent important initiatives that could provide significant growth over the next decade.",0.7467645406723022,0.011023162864148617,0.24221231043338776,positive,0.735741376876831
27,2018-08-31 08:09:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
28,2018-08-31 08:09:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
29,2018-08-31 08:09:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
30,2018-08-31 08:09:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
31,2018-08-31 08:09:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
32,2018-08-31 08:09:00,Brian Stoffel owns shares of Veeva Systems.,0.016026807948946953,0.010143947787582874,0.9738292694091797,neutral,0.0058828601613640785
33,2018-08-31 08:09:00,The Motley Fool owns shares of and recommends Veeva Systems.,0.034477271139621735,0.013045232743024826,0.9524774551391602,neutral,0.02143203839659691
34,2018-08-31 08:09:00,The Motley Fool owns shares of Oracle and has the following options: long January 2020 $30 calls on Oracle.,0.029560379683971405,0.1700759381055832,0.8003636002540588,neutral,-0.14051556587219238
35,2018-08-31 08:09:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
36,2018-08-31 08:09:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
